Jane Wasman
2014
In 2014, Jane Wasman earned a total compensation of $2.3M as President, International, General Counsel and Corporate Secretary at Acorda Therapeutics, a 8% increase compared to previous year.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Non-Equity Incentive Plan | $354,672 |
| Option Awards | $1,091,583 |
| Salary | $535,492 |
| Stock Awards | $324,885 |
| Other | $7,650 |
| Total | $2,334,282 |
Wasman received $1.1M in option awards, accounting for 47% of the total pay in 2014.
Wasman also received $20K in bonus, $354.7K in non-equity incentive plan, $535.5K in salary, $324.9K in stock awards and $7.7K in other compensation.
Rankings
In 2014, Jane Wasman's compensation ranked 3,917th out of 13,032 executives tracked by ExecPay. In other words, Wasman earned more than 69.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,917 out of 13,032 | 70th |
Division Manufacturing | 1,387 out of 4,966 | 72nd |
Major group Chemicals And Allied Products | 450 out of 1,686 | 73rd |
Industry group Drugs | 348 out of 1,365 | 75th |
Industry Biological Products, Except Diagnostic Substances | 59 out of 236 | 75th |
Source: SEC filing on April 21, 2017.
Wasman's colleagues
We found six more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2014.
2014
Andrew Hindman
Acorda Therapeutics
Chief Business Development Officer
2014
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2014
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2014
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2014
David Lawrence
Acorda Therapeutics
Chief, Business Operations and Principal Accounting Officer
2014
Michael Rogers
Acorda Therapeutics